Eliem Therapeutics, Inc. (ELYM)

Eliem Therapeutics Analyst Ratings

• Total Analysts: n/a
• Consensus Rating: n/a
• Price Target: n/a
• Upside: n/a

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $6	Hold	Reiterates	$6	-11.89%	Mar 8, 2023
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Feb 10, 2023
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $6	Strong Buy	Initiates	$6	-11.89%	Oct 28, 2022
Marc Goodman SVB Leerink	SVB Leerink	Buy Maintains $9 → $4	Buy	Maintains	$9 → $4	-41.26%	Aug 16, 2022
Marc Goodman SVB Leerink	SVB Leerink	Buy Maintains $13 → $9	Buy	Maintains	$13 → $9	+32.16%	Jul 11, 2022
Yatin Suneja Guggenheim	Guggenheim	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Apr 26, 2022
Marc Goodman SVB Leerink	SVB Leerink	Buy Maintains $33 → $13	Buy	Maintains	$33 → $13	+90.90%	Apr 26, 2022
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Sep 7, 2021
Paul Matteis Stifel	Stifel	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Sep 7, 2021
Marc Goodman SVB Leerink	SVB Leerink	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Sep 7, 2021